Tenpoint Therapeutics Launches National ‘Friends of the Presbyopians’ Campaign to Raise Awareness of YUVEZZI for Age-Related Near Vision Loss
Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company dedicated to developing innovative therapies that improve vision in the aging eye, has announced the launch of its first nationwide consumer awareness campaign for YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%. The campaign, titled “Friends of the Presbyopians,” is designed to encourage people experiencing age-related blurry near vision to recognize the impact of presbyopia on their daily lives and explore available prescription treatment options.
The campaign supports the commercial rollout of YUVEZZI, which is the first and only dual-agent, once-daily prescription eye drop approved by the U.S. Food and Drug Administration (FDA) for the treatment of presbyopia. By combining education with humor and creative storytelling, Tenpoint Therapeutics aims to increase public awareness of a condition that affects millions of adults but is often accepted as an inevitable part of aging rather than a treatable vision disorder.
Addressing a Common Age-Related Vision Condition
Presbyopia is one of the most widespread vision changes associated with aging. The condition develops gradually as the eye’s natural lens loses flexibility, making it increasingly difficult to focus on nearby objects. For many individuals, symptoms begin to appear around the age of 45 and progressively worsen over time.
According to estimates, approximately 128 million adults in the United States and nearly 2 billion people worldwide are affected by presbyopia. Despite its prevalence, many people simply adapt to the condition by changing their daily habits rather than seeking medical treatment.
Common challenges associated with presbyopia include difficulty reading books or menus, viewing smartphone screens, checking product labels while shopping, reading medication instructions, completing paperwork, or performing hobbies that require close visual focus. These seemingly minor inconveniences can accumulate throughout the day, affecting productivity, independence, and overall quality of life.
A Creative Campaign with Everyday Objects as the Stars
Rather than relying on traditional advertising, Tenpoint Therapeutics has developed a distinctive campaign centered on a cast of handcrafted puppet characters that represent everyday objects frequently used by people living with presbyopia.
The campaign introduces humorous personalities including:
- A restaurant menu frustrated by constantly being stretched to arm’s length.
- A smartphone tired of being squinted at throughout the day.
- A pair of reading glasses exhausted from being misplaced, dropped, and repeatedly searched for.
Each character humorously “complains” about the excessive demands placed upon it by individuals struggling with blurry near vision.
Through these playful stories, the campaign highlights many of the common workarounds people adopt without realizing there may be prescription treatment options available.
Instead of focusing solely on vision problems, “Friends of the Presbyopians” emphasizes the everyday habits and adjustments that become second nature for many adults experiencing presbyopia.
Encouraging Conversations About Vision Health
According to Tenpoint Therapeutics, one of the primary goals of the campaign is to encourage individuals to recognize that blurry close-up vision is more than just a normal part of aging that must be endured.
Henric Bjarke, Chief Executive Officer of Tenpoint Therapeutics, said the nationwide campaign represents an important milestone in the company’s commercial strategy as it continues expanding awareness of YUVEZZI.
He noted that millions of adults experience frustrating episodes of blurry near vision every day while carrying out routine activities. By using humor and relatable storytelling, the campaign seeks to initiate conversations about how presbyopia affects daily life and motivate people to learn more about available treatment options, including YUVEZZI.
The campaign reflects Tenpoint’s broader commitment to helping patients understand that advances in ophthalmic medicine have created alternatives beyond simply relying on reading glasses.
Bringing the Characters to Life
To develop the campaign’s unique visual identity, Tenpoint Therapeutics partnered with an accomplished creative team specializing in practical puppetry and visual storytelling.
The project was directed by award-winning filmmaker Spencer Susser and featured contributions from experienced puppet designers and fabricators, including veteran puppeteer Ben Bayouth, who gained recognition as a finalist on Jim Henson’s Creature Shop Challenge.
The campaign combines traditional handcrafted puppets with modern animatronic technology to create expressive characters capable of delivering humorous yet relatable performances.
This blend of craftsmanship and storytelling was chosen to create memorable characters that resonate emotionally with audiences while highlighting the everyday realities of living with presbyopia.
The “Friends of the Presbyopians” campaign is being introduced across digital platforms and social media channels nationwide.
Highlighting Everyday Experiences
Carol Kearney, Chief Commercial Officer of Tenpoint Therapeutics, explained that research with individuals living with presbyopia revealed that the condition is rarely defined by one dramatic moment.
Instead, people described a series of daily adjustments that gradually become routine.
These include:
- Squinting to read small print
- Holding reading material farther away, often referred to as the “arm trombone”
- Constantly searching for misplaced reading glasses
- Using brighter lighting or smartphone flashlights
- Repeatedly switching between different pairs of glasses
According to Kearney, the campaign was designed to capture these familiar situations with warmth, humor, and a sense of nostalgia.
By allowing ordinary objects to “speak” about their experiences, the campaign encourages viewers to reconsider whether blurry close-up vision should simply be accepted or discussed with an eye care professional.
About YUVEZZI
YUVEZZI is approved by the FDA as a once-daily prescription ophthalmic solution for adults with presbyopia.
Unlike reading glasses, which provide an external optical aid, YUVEZZI is intended to improve near vision through a pharmacological approach.
The product combines carbachol and brimonidine tartrate in a dual-agent formulation designed to support improved close-up vision during daily activities.
According to clinical studies, YUVEZZI may be used:
- As an alternative to reading glasses
- Alongside contact lenses
- Together with prescription glasses used primarily for distance vision
This flexibility allows patients to integrate the therapy into their existing vision correction routines based on individual needs and physician recommendations.
Clinical Performance
Clinical trial results demonstrated encouraging improvements in near vision following treatment with YUVEZZI.
Study findings showed that the eye drops provided:
- Up to eight continuous hours of improved close-up vision
- Noticeable effects beginning as early as 30 minutes after administration for some patients
Researchers also observed that some individuals were able to read at least three additional lines on a near vision eye chart under low-light conditions without sacrificing their ability to see distant objects.
These findings suggest that YUVEZZI may help patients perform visually demanding daily activities such as reading, working on digital devices, shopping, and other close-up tasks during much of the day.
Safety Profile
The safety profile observed during clinical studies was generally favorable.
The most commonly reported side effects included:
- Headache
- Temporary blurred or impaired vision
- Mild eye pain during administration
- Eye irritation immediately after instillation
According to Tenpoint Therapeutics, most adverse events were mild, short in duration, and resolved without requiring additional treatment.
However, YUVEZZI should not be used by individuals who are allergic to any of its ingredients or by patients who currently have iritis, an inflammatory condition affecting the iris of the eye.
Patients are encouraged to consult their eye care professionals regarding appropriate use and whether the therapy is suitable for their individual medical history.
Expanding Awareness Through Innovation
The launch of the “Friends of the Presbyopians” campaign represents more than a marketing initiative; it reflects Tenpoint Therapeutics’ broader strategy to reshape how presbyopia is perceived and managed. By combining creative storytelling, relatable everyday experiences, and education about available prescription therapies, the company hopes to encourage millions of adults to reconsider the common assumption that declining near vision is simply an unavoidable consequence of aging.
With YUVEZZI offering the first FDA-approved once-daily dual-agent prescription eye drop for presbyopia, Tenpoint aims to expand awareness of treatment options while supporting conversations between patients and eye care professionals. As the campaign rolls out across digital and social platforms nationwide, it has the potential to help many individuals better understand their condition, explore new approaches to vision care, and improve their ability to perform the everyday tasks that matter most.
About YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%
YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a once-daily, dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a condition characterized by the gradual loss of close-up vision that typically begins around age 45.
